3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
ruxolitinib
5
Filgrastim
4
Decitabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Methylprednisolone
3
Etoposide
3
Topotecan
2
Tacrolimus
2
Prednisone
2
LY2784544
2
Cytarabine
2
Cyclosporine
2
Carboplatin
2
Antilymphocyte Serum
2
veliparib
1
tipifarnib
1
talazoparib
1
spartalizumab
1
sonidegib
1
sargramostim
1
sabatolimab
1
romidepsin
1
pyroxamide
1
poly ICLC
1
peginterferon alfa-2a
1
nelarabine
1
navitoclax
1
arsenous acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Thrombocythemia, Essential
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled